Sara Hogan, MD
Procedural Dermatology · Washington, DCNPI 1295153997
Payments from drug & device makers
Across 191 payments — averaging $164.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$25K
- Solta Medical, A Division Of Bausch Health US, LLC$3K
- Galderma Laboratories, L.p.$572
- Incyte Corporation$390
- Johnson & Johnson$262
- Merz North America, Inc.$242
- plus $2K from 21 others
What the payments were for
- Consulting fees$5,01716%
- Speaking & faculty fees$20,15064%
- Travel & lodging$2031%
- Food & beverage$6,04619%
- Education$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $25,222 |
| Solta Medical, A Division Of Bausch Health US, LLC | 7 | $2,971 |
| Galderma Laboratories, L.p. | 23 | $572 |
| Incyte Corporation | 15 | $390 |
| Johnson & Johnson | 10 | $262 |
| Merz North America, Inc. | 6 | $242 |
| Pfizer | 11 | $240 |
| Sanofi | 7 | $197 |
| Lilly USA, LLC | 7 | $156 |
| Sun Pharmaceutical Industries Inc. | 7 | $154 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $140 |
| Novartis | 5 | $139 |
| LEO Pharma Inc. | 5 | $137 |
| Dermavant Sciences, Inc. | 1 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $122 |
| UCB, Inc. | 4 | $81 |
| Genentech USA, Inc. | 3 | $55 |
| Bristol Myers Squibb | 2 | $47 |
| Aclaris Therapeutics, Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Boehringer Ingelheim | 1 | $33 |
| Amgen | 1 | $31 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Almirall LLC | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$6,645
- Clear & Brilliant$2,523
- KYBELLA$145
- VTAMA$134
- Tremfya$122
How this compares
Too few procedural dermatology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 23 | $1,204 |
| Ketoconazole | 40 | $643 |
| Clindamycin Phosphate | 13 | $476 |
| Betamethasone Dipropionate | 11 | $456 |
| Triamcinolone Acetonide | 37 | $391 |
| Nystatin | 15 | $199 |
| Mupirocin | 25 | $189 |
| Hydrocortisone | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Washington
- Cheryl BurgessWashington$2.4M
- Nina HartmanWashington$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.